Sanders Morris Harris’s Rocket Pharmaceuticals RCKT Stock Holding History

Sanders Morris Harris’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-27,709	Closed	-$99.2K	–	239
2026 Q1	$99.2K	Buy	+27,709	New	+$110K	0.02%	280
2025 Q4	–	Sell	-27,709	Closed	-$90.3K	–	243
2025 Q3	$90.3K	Buy	+27,709	New	+$87.3K	0.01%	292
2025 Q2	–	Sell	-27,709	Closed	-$161K	–	277
2025 Q1	$161K	Hold	27,709	–	–	0.02%	260
2024 Q4	$348K	Hold	27,709	–	–	0.05%	203
2024 Q3	$512K	Hold	27,709	–	–	0.08%	153
2024 Q2	$597K	Hold	27,709	–	–	0.1%	139
2024 Q1	$746K	Hold	27,709	–	–	0.14%	116
2023 Q4	$814K	Hold	27,709	–	–	0.4%	63
2023 Q3	$542K	Hold	27,709	–	–	0.11%	143
2023 Q2	$553K	Buy	+27,709	New	+$560K	0.12%	125
2023 Q1	–	Sell	-27,709	Closed	-$542K	–	230
2022 Q4	$542K	Hold	27,709	–	–	0.21%	108
2022 Q3	$430K	Hold	27,709	–	–	0.11%	157
2022 Q2	$400K	Hold	27,709	–	–	0.09%	180
2022 Q1	$439K	Hold	27,709	–	–	0.09%	182
2021 Q4	$646K	Hold	27,709	–	–	0.11%	140
2021 Q3	$824K	Hold	27,709	–	–	0.15%	107
2021 Q2	$1.25M	Hold	27,709	–	–	0.24%	79
2021 Q1	$1.16M	Hold	27,709	–	–	0.25%	75
2020 Q4	$1.54M	Hold	27,709	–	–	0.35%	58
2020 Q3	$772K	Buy	+27,709	New	+$683K	0.21%	100

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Sanders Morris Harris's RCKT Position: Q2 2026 in Review

Sanders Morris Harris sold out of Rocket Pharmaceuticals (RCKT) in Q2 2026, closing a stake of 27,709 shares — an estimated $99.2K sold.

Sanders Morris Harris first reported a position in RCKT in Q3 2020 and held it in 20 quarters. The position peaked at $1.54M in Q4 2020. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

Sanders Morris Harris reported no remaining Rocket Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Sanders Morris Harris sold 27,709 Rocket Pharmaceuticals shares in Q2 2026, an estimated $99.2K.
Sanders Morris Harris first reported a position in Rocket Pharmaceuticals in Q3 2020 and held it in 20 quarters.
Sanders Morris Harris's Rocket Pharmaceuticals position peaked at $1.54M in Q4 2020.
180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Sanders Morris Harris's 13F filing for Q2 2026, filed 7 Jul 2026.